Elite Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Elite Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$724K	Sell	11,752 -2,225	-16%	-$146K	1.18%	23
2016 Q2	$885K	Sell	13,977 -2,816	-17%	-$177K	1.46%	21
2016 Q1	$1.01M	Buy	16,793 +1,431	+9%	+$87.5K	1.42%	20
2015 Q4	$1.07M	Buy	15,362 +3,462	+29%	+$245K	1.6%	21
2015 Q3	$789K	Sell	11,900 -4,106	-26%	-$319K	1.24%	32
2015 Q2	$1.25M	Sell	16,006 -1,626	-9%	-$127K	1.3%	25
2015 Q1	$1.35M	Buy	+17,632	New	+$1.3M	1.19%	30

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Elite Wealth Management's PJP Position: Q3 2016 in Review

Elite Wealth Management reduced its Invesco Pharmaceuticals ETF (PJP) stake by 16% in Q3 2016, selling an estimated $146K and leaving 11,752 shares worth $724K. The position accounts for 1.18% of the portfolio, ranked #23.

Elite Wealth Management first reported a position in PJP in Q1 2015 and has held it in 7 quarters since. The position peaked at $1.35M in Q1 2015. 96 funds tracked by Wall St. Rank hold PJP as of Q3 2016.

Elite Wealth Management held 11,752 shares of Invesco Pharmaceuticals ETF worth $724K as of Q3 2016.
Elite Wealth Management sold 2,225 Invesco Pharmaceuticals ETF shares in Q3 2016, an estimated $146K.
Invesco Pharmaceuticals ETF made up 1.18% of Elite Wealth Management's portfolio in Q3 2016, its #23 holding.
Elite Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q1 2015 and has held it in 7 quarters since.
Elite Wealth Management's Invesco Pharmaceuticals ETF position peaked at $1.35M in Q1 2015.
96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2016.

Based on Elite Wealth Management's 13F filing for Q3 2016, filed 23 Nov 2016.